Portage Biotech Inc.
PRTG
$8.10
-$1.01-11.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 91.02% | 79.45% | 40.47% | 34.67% | 27.98% |
| Total Depreciation and Amortization | -35.19% | -7.32% | 59.26% | 325.00% | 5,300.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -100.41% | -83.43% | -41.11% | -40.13% | -35.16% |
| Change in Net Operating Assets | 54.58% | 885.59% | -62.67% | 1,454.17% | 9,920.00% |
| Cash from Operations | 61.80% | 52.86% | 35.24% | 6.14% | -18.42% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 557.98% | 557.98% |
| Cash from Investing | -- | -- | -- | 555.75% | 555.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -17.50% | -60.71% | -147.06% | 97.91% | 98.00% |
| Issuance of Common Stock | -64.27% | -86.89% | 45.72% | 49.11% | 101.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 109.30% | 107.27% | 100.63% | 98.91% |
| Cash from Financing | -64.75% | -87.16% | 49.99% | 994.89% | 5,200.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 39.13% | 53.32% | 85.50% | 67.62% | 56.92% |